RxDoctor Payments Data

Sameen Nooruddin

Obstetrics & Gynecology · Houston, TXNPI 1568825693

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 87 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 24.1% of the total. Reporting peaked in 2023 at $431 and has fallen 62.5% since, to $161 in 2025.

$1,779in general payments, 2019–2025

Across 87 payments — averaging $20.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$429
  • Exeltis, USA Inc.$151
  • Sumitomo Pharma America, Inc.$142
  • Myovant Sciences Inc.$133
  • Bayer$108
  • Hologic Sales And Service, LLC$84
  • plus $731 from 21 others

What the payments were for

  • Food & beverage$1,779100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,779 in reported general payments places this provider in the 65th percentile of 3,099 obstetrics & gynecology providers in Texas.

See all obstetrics & gynecology providers in Texas →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol12$1,164

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Houston

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →